Seeking Alpha

CORT
Corcept Therapeutics Incorporated

5/22/2012, 10:03 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
CORT Market Currents more »
  • March 22 Leerink Swann says the pricing for Corcept's (CORT -0.8%) Korlym is higher than expected at $186 per 300mg tablet, which should help offset its caution regarding patient numbers. The drug developer announced this morning it will begin shipping Korlym starting April 11.
    1 Comment
    [Healthcare]
CORT in Focus more »
CORT Latest Transcript more »
Currently, there are no transcripts for CORT.
CORT Cramer more »
Currently, there are no Cramer articles on CORT.
CORT Instablog posts more »
  • CGTS OPTIONS CORNER: FOR WEDNESDAY 6/15/11 -- Is This A Trading Bottom?
    Tue, Jun 14, 2011 • Michael Clark • Comment!
  • Top Biotech Stocks for 2011 and January Catalyst Event Dates.
    Thu, Jan 27, 2011 • BioPharma Investor • Comment!
  • CGTS TOP AND BOTTOM WARNING WATCHLIST, FOR MONDAY 18 OCT 2010
    Mon, Oct 18, 2010 • Michael Clark • Comment!
  • CGTS Daily Trading Signals: For Monday, 20 September 2010. Short Yahoo and DSX. Buy Nano. Sell the Banks!
    Sun, Sep 19, 2010 • Michael Clark • 2 Comments
  • New Biotech Milestones and Database Updates for July 26, 2010
    Mon, Jul 26, 2010 • Andrew Nava • Comment!
Write a post on CORT
CORT StockTalks
CORT vs. ETF Alternatives
Company Description
Currently, there's no company description for CORT.
Sector: Healthcare
Industry: Biotechnology
Country: United States